IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform
Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits
Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity In
BioTrinity 2025: Over 800 professionals convene to paint a picture of hope for UK life sciences
BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024.Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements.Nearly 10,000 meetings requested, with 2,000
FairJourney Biologics establishes Supervisory Board
Werner Lanthaler appointed as Chair and joined by global industry leadersThe Supervisory Board will define key avenues for growth, accelerate innovation, and optimize scientific strategies to maintain leadership in antibody discovery and development
US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies
London, UK, 24 March 2025: Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, announces the expansion of its US patent portfolio.
Sapio Sciences makes AI-native drug discovery seamless with NVIDIA BioNeMo
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle
Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing
HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of XP-Design Assay Salmonella Serotyping Solution designed for the rapid detection and precise characterization of
H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai
Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in India
Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline
Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium PharmaceuticalsCambridge, UK, 12 March 2025:&
OBN invites life science R&D companies, industry leaders, academics, and investors to BioTrinity 2025
Opening keynote from Tim Haines, Executive Partner at Abingworth, to provide a review of the life science investment landscapeExpected to welcome c900 delegates [SB1] spanning early-stage life science R&D,
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics based on the Company’s TRIMTACTM
Centauri Therapeutics selects first clinical candidate, for immunotherapeutic treatment of Gram-negative bacterial infections
Lead candidate in the ABX-01 programme to progress into first-in-human clinical studies Programme designed to treat Gram-negative bacterial lung infections in the most vulnerable patientsLondon, UK, 4 March 2025: Centauri Therapeu
FairJourney Biologics acquires Charles River Laboratories South San Francisco facility
Acquisition of Charles River site, previously Distributed Bio, strengthens antibody discovery capabilities with SuperHuman libraries and Yeast Display platformEstablished presence in major North American biotechnology cluster extends FairJourney’s global reach
Sapio Sciences expands leadership team to drive growth
Mike Hampton Joins as Chief Commercial Officer, and New Scientific Office Strengthens Sapio’s AI-Driven Lab Informatics Leadership
Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology
Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior AdvisorExpansion into global AI hub to accelerate growth of IP portfolio and progress toward key technical milestones
Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success
Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development
Ready-to-use kits expand portfolio of host cell protein impurity kits, for quantification of host cell proteins from HEK293 cell lines Kits developed through a collaboration with BioGenes GmbHUppsala, Sweden, 05 February 2025:
Sapio Sciences selected by LabConnect to transform laboratory operations
Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation
Trilobio introduces whole-laboratory automation platform at SLAS2025
· First public demonstration of unified robotics, device and software platform to be showcased at SLAS2025, 25-29 January, in San Diego, CA. Booth 2115
Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure
Configurable informatics platform improves lab efficiency, data tracking, and resource management from plasmid to structure
Bio-Rad launches TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits for Antibody Conjugation to StarBright Dyes
New Kits Offer Broad Antibody Compatibility and Long-Term Stability for Flow Cytometry and Western Blot Applications
Tecan introduces Veya: bringing digital, scalable automation to labs worldwide
Multiomics platform streamlines workflows and provides real-time insights, optimizing resource usage and ensuring smooth, data-driven operations
Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery Company also announces key accreditations in recognition of excellence in data security,
Bio-Rad extends range of Vericheck ddPCR Empty-Full Capsid Kits to optimize AAV Vector Characterization
New Vericheck ddPCR Empty-Full Capsid Kits for AAV Serotypes 2 and 8 Provide Precise Measurement of Viral Titer and Capsid Titer, Supporting Reliable Assessment of AAV Vector Quality
FUJIFILM Irvine Scientific sells its medical media business to Astorg
Singular focus on life sciences will accelerate the strategic growth of the company and expansion of its products and services to the market